Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic, Zepbound and weight loss
Why Ozempic, Zepbound, and other weight-loss drug dupes carry risks
Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
Off-brand Ozempic, Zepbound and other weight loss products carry undisclosed risks for consumers
Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ingredients that may lack the purity of the branded medications.
Next-gen weight loss drugs will have fewer side effects than Ozempic, pharma CEO says
Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s designed to work differently from those currently on the market and with the potential for fewer side effects.
34m
FDA To Reassess Ban On Cheaper, Compounded Versions of Eli Lilly Weight Loss Drugs
The FDA resolved the shortage of Eli Lilly's tirzepatide, but may revisit allowing compounding pharmacies to make copies, ...
17m
on MSN
Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?
With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...
4d
on MSN
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
Men, Baby Boomers, and postgraduate degree-holders were among those most likely to say they wouldn’t choose medication over ...
3d
on MSN
Wegovy and Zepbound rival targeting ‘next generation' of obesity drugs, Zealand Pharma CEO says
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...
1d
on MSN
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold ...
MedPage Today
33m
Nurse in Critical Condition; JD Vance's Mom Got Obamacare; Bird Flu Cluster Grows
Three Philadelphia nurses attempting to care for a gunshot victim were struck by the same vehicle that dropped off the ...
10d
Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
2h
Lilly to Invest $364 Million in UK Biotech, Obesity Research
Eli Lilly & Co plans to invest £279 million ($364 million) in a new initiative to support UK biotechs along with a study of ...
5d
Trade group sues FDA over ending Mounjaro/Zepbound shortage
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
Daily Reporter
2h
Why Lilly is pouring billions into LEAP
Lilly’s latest investment comes on the heels of three earlier rounds of manufacturing investment at the LEAP Research and ...
Verywell Health on MSN
3d
Zepbound (Tirzepatide) vs. Wegovy (Semaglutide): How Do They Compare?
These drugs work similarly but differ in dosage and specific indications (uses). Research suggests that tirzepatide is more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Eli Lilly
Mounjaro
Wegovy
Tirzepatide
weight loss drugs
Feedback